FATE vs MCHP · rev $3.4M vs rev $4.71B
Fate Therapeutics Inc (FATE) versus Microchip Technology Inc (MCHP) — a side-by-side from cached financials, not a winner call.
Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
Microchip Technology Inc (MCHP) is a semiconductors company listed on US.
Latest reported FATE revenue for 2026-06-30 was $3.4M. Net income was -$61.4M. FATE currently screens at market cap $331.0M.
Latest reported MCHP revenue for 2026-03-31 was $4.71B. Net income was $230.0M. Revenue was up 7.1% from 2025-03-31 to 2026-03-31. MCHP currently screens at market cap $39.41B.
FATE currently screens at market cap $331.0M. MCHP currently screens at market cap $39.41B.
Not investment advice. Open the FATE and MCHP stock pages for the full models.
Not investment advice.